Skip to main content

Table 1 Demographic and clinical characteristics of the patients

From: Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study

 

Index group with oedema (n = 7)

Reference group without oedema (n = 7)

P value

Age (years)

58 (32–85)

49 (21–71)

0.39

Men

5 (71%)

6 (86%)

 

Length (cm)

171 (165–185)

176 (165–185)

0.26

Weight at admission (kg)

68 (47–80)

77 (65–90)

0.20

Weight at study day (kg)

89 (65–107)

77 (65–85)

0.09

Weight gain (kg)

21 (31%)

1 (1%)

0.001

BMI at admission (kg/m2)

23.4 (16.3–27.6)

24.8 (21.0–30.4)

0.47

BMI at study day (kg/m2)

30.6 (22.5–37.9)

25.0 (21.5–30.4)

0.04

SOFA score

4 (3–5)

5 (3–6)

0.41

Creatinine clearance (ml/minute)

71 (36–109)

131 (85–168)

0.003

Mean arterial pressure (mmHg)

91 (80–115)

95 (79–122)

0.64

Diagnosis (number)

   

   Sepsis

4

0

 

   Neurotrauma

1

2

 

   Intoxication

1

0

 

   Pneumonia

0

1

 

   Multitrauma

0

2

 

   Exacerbation COPD

0

1

 

   Perforated appendicitis

1

0

 

   Cerebral bleeding

0

1

 
  1. Data are means with ranges in parentheses unless otherwise specified. BMI, body mass index; COPD, chronic obstructive pulmonary disease; SOFA, sequential organ failure assessment.